Regen BioPharma Inc. (OTCQB: RGBP), (OTCQB: RGBPP) is pleased to announce that Xiaojing Ma, Ph.D. has agreed to serve in the consulting role as the Company’s Senior Research Advisor. Specifically, he will be assisting Dr. Lander in pre-clinical research design and execution of cellular and animal experiments for the Company’s NR2F6 program.

Leave a Reply

Your email address will not be published.